8-K filed May 30, 2024, 7:59 PM ET ticker SCNX CIK 0001382574

regulatory confidence high sentiment negative materiality 0.75

TRxADE Health receives Nasdaq non-compliance notice for late Q1 10-Q; directors resign, new ones appointed

Scienture Holdings, Inc.

Received Nasdaq notice on May 23, 2024 for failing to timely file Q1 10-Q; must submit compliance plan by July 22, 2024.
Potential extension to Nov 18, 2024; no immediate effect on listing or trading.
Appointed Mayur Doshi (CEO of AlfaGene Bioscience) and Narasimhan Mani (former CEO of Kesin Pharma) as directors on May 28, 2024.
Directors Jeff Newell and Michael Peterson voluntarily resigned on May 30, 2024; no dispute with the Company.
Resigned directors receive cash compensation through June 30, 2024; unvested shares fully vested on resignation date.

item 3.01 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeff Newell

Director

SCNX · Scienture Holdings, Inc.

Effective: 2024-05-30
Filed: May 30, 2024, 7:59 PM ET

On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.

Appointed

Narasimhan Mani

Director

SCNX · Scienture Holdings, Inc.

Effective: 2024-05-28
Filed: May 30, 2024, 7:59 PM ET

On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.

Departed

Michael L. Peterson

Director

SCNX · Scienture Holdings, Inc.

Effective: 2024-05-30
Filed: May 30, 2024, 7:59 PM ET

On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.

Appointed

Mayur Doshi

Director

SCNX · Scienture Holdings, Inc.

Effective: 2024-05-28
Filed: May 30, 2024, 7:59 PM ET

On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeff Newell resigned as Director at Scienture Holdings, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael L. Peterson resigned as Director at Scienture Holdings, Inc..

Action: resigned
Role: Director

Exact text from the filing

On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mayur Doshi was appointed as Director at Scienture Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.

View on SEC.gov

Scienture Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-021967

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.